Benefit of Apabetalone on Plasma Proteins in Renal Disease

Wasiak, S; Tsujikawa, LM; Halliday, C; Stotz, SC; Gilham, D; Jahagirdar, R; Kalantar-Zadeh, K; Robson, R; Sweeney, M; Johansson, JO; Wong, NC; Kulikowski, E

Kulikowski, E (reprint author), Resverlogix Corp, Suite 300,4820 Richard Rd SW, Calgary, AB T3E 6L1, Canada.

KIDNEY INTERNATIONAL REPORTS, 2018; 3 (3): 711

Abstract

Introduction: Apabetalone, a small molecule inhibitor, targets epigenetic readers termed BET proteins that contribute to gene dysregulation in human d......

Full Text Link